Metformin treatment status and abdominal aortic aneurysm disease progression. - Wikidata - wikimedia - TriplyDB

Metformin treatment status and abdominal aortic aneurysm disease progression.

Metformin treatment status and abdominal aortic aneurysm disease progression.

http://www.wikidata.org/entity/Q37047861

about

Association between use of oral-antidiabetic drugs and the risk of aortic aneurysm: a nested case-control analysis.5th International Meeting on Aortic Diseases: New Insights into an Old Problem.Effect of AMPK signal pathway on pathogenesis of abdominal aortic aneurysms.Hypoxia-inducible factor 1 in clinical and experimental aortic aneurysm disease.Meta-analysis of the association between peripheral artery disease and growth of abdominal aortic aneurysms.NLRP3 (Nucleotide Oligomerization Domain-Like Receptor Family, Pyrin Domain Containing 3)-Caspase-1 Inflammasome Degrades Contractile Proteins: Implications for Aortic Biomechanical Dysfunction and Aneurysm and Dissection Formation.Association between metformin prescription and growth rates of abdominal aortic aneurysms.Association of abdominal aortic aneurysm diameter with insulin resistance index

P2860

Q37228390-7F78F48F-B01C-4E95-9234-E4C3B2378A23 Q45989957-A6F57293-EE5C-4CBB-8821-BD1E86CFA16C Q47099255-D755AAE2-5D4F-411E-8CA2-707811C7262C Q47292596-C7CCFAFE-F3F8-4080-BCB7-0DFEADC31333 Q47770057-73443D43-001E-421E-9A12-7B2E2007789B Q51155749-DB4B3CA5-1ED8-4F45-90C9-BED0656DD9BC Q51345562-2528DE47-4F1B-47E7-8AA3-5C8D2BE4AC50 Q59138196-BE187385-C8E1-4095-9E4D-642BB9F789EB

P2860

Metformin treatment status and abdominal aortic aneurysm disease progression.

http://www.wikidata.org/entity/Q37047861

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 19 April 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Metformin treatment status and abdominal aortic aneurysm disease progression.

@en

Metformin treatment status and abdominal aortic aneurysm disease progression.

@nl

type

label

Metformin treatment status and abdominal aortic aneurysm disease progression.

@en

Metformin treatment status and abdominal aortic aneurysm disease progression.

@nl

prefLabel

Metformin treatment status and abdominal aortic aneurysm disease progression.

@en

Metformin treatment status and abdominal aortic aneurysm disease progression.

@nl

P1433

Q37047861-9722F3BB-6289-4016-9273-A42BA0A2983E

P1476

Q37047861-98C41E04-5A99-4E0A-9EC4-A5EABD73E8D3

P2093

Q37047861-02F0578D-5637-4875-A669-FE441D77A652

Q37047861-1CAE4812-D14A-4685-942E-CD34424C1244

Q37047861-1DF16C1A-CC91-49FB-BC69-B185A264B72A

Q37047861-A1E0D02D-59CB-4AEB-A210-0E992E32BDEB

Q37047861-C10DFBAA-8A58-43E6-AC08-B77AF502A4AB

Q37047861-E66AA504-DB6D-4514-B865-5E294B150917

P2860

Q37047861-045A5A4D-FFB7-4301-97AE-D9A48D3F1D35

Q37047861-07C0EAD8-8E05-480F-8C0D-740D4A073C39

Q37047861-0CAF5F6A-F7F9-44F3-AAF2-F0EAECFE5FCF

Q37047861-15C098F4-C460-4756-8B5D-45F0BCFF8633

Q37047861-174A6CDF-84FF-4C46-A076-817E161D2910

Q37047861-1A471895-EEE3-4BD5-BF4D-A103839BDA5C

Q37047861-1F99FFFC-DD8C-4011-8593-C904A927F4F2

Q37047861-241A8EE8-7F08-42BD-BB7D-3CA070CC9237

Q37047861-2F664A67-871A-43CF-B080-E572A7A6211F

Q37047861-308D921E-5DC8-4020-852F-79D758099731

P304

Q37047861-460098A0-652D-403C-AB98-C3E763C56413

P31

Q37047861-156DB175-5AFA-41CE-B1AA-4A4403BF8C1E

P356

Q37047861-D27517C3-1AF8-4F52-8AC9-61FB969C248C

P433

Q37047861-21ACB64E-9427-4D84-9694-E4AE2B320D1C

P478

Q37047861-E7F14C58-279B-4494-8E0E-AC9D41547A40

P50

Q37047861-BCEC0F92-BE18-4F83-8D91-2AD87F1C03BE

Q37047861-C5E65B53-E0E3-47F2-BFCF-26DE36E1D006

P577

Q37047861-DB1363A0-4BF3-4F4B-A965-5527DDC1584B

P698

Q37047861-4E9B7387-BEB8-47C3-A7ED-4B46D0ED75DF

P921

Q37047861-2F7C117E-4E76-4971-898A-ABF1DE8B84B0

P932

Q37047861-C0C87E98-C04A-4F2A-8999-93EB086C791A

P356

J.JVS.2016.02.020

P1433

Journal of Vascular Surgery

P1476

Metformin treatment status and abdominal aortic aneurysm disease progression.

@en

P2093

Baohui Xu

http://www.w3.org/2001/XMLSchema#string

Haojun Xuan

http://www.w3.org/2001/XMLSchema#string

Keith J Glover

http://www.w3.org/2001/XMLSchema#string

Matthew W Mell

http://www.w3.org/2001/XMLSchema#string

Naoki Fujimura

http://www.w3.org/2001/XMLSchema#string

Ronald L Dalman

http://www.w3.org/2001/XMLSchema#string

P2860

Metformin: An Old Drug for the Treatment of Diabetes but a New Drug for the Protection of the Endothelium

Diabetes and cancer: a consensus report.

Functional evaluation of out-of-the-box text-mining tools for data-mining tasks.

STRIDE--An integrated standards-based translational research informatics platform.

Systematic review and meta-analysis of the effects of statin therapy on abdominal aortic aneurysms.

Hyperglycemia modulates plasminogen activator inhibitor-1 expression and aortic diameter in experimental aortic aneurysm disease.

Anti-receptor for advanced glycation end products therapies as novel treatment for abdominal aortic aneurysm

Peptide inhibitor of CXCL4-CCL5 heterodimer formation, MKEY, inhibits experimental aortic aneurysm initiation and progression

Meta-analysis of individual patient data to examine factors affecting growth and rupture of small abdominal aortic aneurysms.

Hyperglycemia limits experimental aortic aneurysm progression.

P304

46-54.e8

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JVS.2016.02.020

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

64

http://www.w3.org/2001/XMLSchema#string

P50

Ellen B Kettler

P577

2016-04-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27106243

http://www.w3.org/2001/XMLSchema#string

P921

P932

4925242

http://www.w3.org/2001/XMLSchema#string